Bcl-xL silencing induces alterations in hsa-miR-608 expression and subsequent cell death in A549 and SK-LU1 human lung adenocarcinoma cells

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Othman, Norahayu ^a   In, Lionel L A ^a   Harikrishna, Jennifer A ^a,b   Hasima, Noor ^a,b  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

HSA MIR 1304; HSA MIR 181A; HSA MIR 361-5P; HSA MIR 608; HSA MIR 769-5P; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL XL; PROTEIN KINASE B; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; WNT PROTEIN; COMPLEMENTARY RNA; MIRN608 MICRORNA, HUMAN; PROTEIN BCL X;

ANTISENSE THERAPY; APOPTOSIS; ARTICLE; BCL XL GENE; CANCER CELL; CANCER GENE THERAPY; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; GENE SILENCING; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; SIGNAL TRANSDUCTION; ADENOCARCINOMA; CELL SURVIVAL; DEFICIENCY; GENE EXPRESSION REGULATION; GENE THERAPY; GENETICS; LUNG NEOPLASMS; NUCLEOTIDE SEQUENCE; PATHOLOGY; TUMOR CELL LINE; UPREGULATION;

ADENOCARCINOMA; BASE SEQUENCE; BCL-X PROTEIN; CELL DEATH; CELL LINE, TUMOR; CELL SURVIVAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENETIC THERAPY; HUMANS; LUNG NEOPLASMS; MICRORNAS; RNA, ANTISENSE; UP-REGULATION;

EID: 84892428246     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0081735     Document Type: Article

References (40)

1. Daniel JC, Smith R (2004) The role of Bcl-2 family members in nonsmall cell lung cancer. Semin Thorac Cardiovasc Surg 16: 19-27.
2. Hockenbery DM, Zutter M, Hickey W, Nahm M, Korsmeyer SJ (1991) BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci U S A 88: 6961-6965.
3. Fisher TC, Milner AE, Gregory CD, Jackman AL, Aherne GW, et al. (1993) Bcl-2 modulation of apoptosis induced by anticancer drugs: resistance to thymidylate stress is independent of classical resistance pathways. Cancer Res 53: 3321-3326.
4. Miyashita T, Reed JC (1993) Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in human leukemia cell line. Blood 81: 151-157.
5. Tang C, Willingham MC, Reed JC, Miyashita T, Ray S, et al. (1994) High levels of p26BCL-2 oncoprotein retard taxol-induced apoptosis in human pre-B leukemia cells. Leukemia 8: 1960-1969.
6. Liam CK, Pang YK, Leow CH, Poosparajah S, Menon A (2006) Changes in the distribution of lung cancer cell types and patient demography in a developing multiracial Asian country: Experience of a university teaching hospital. Lung Cancer 53: 23-30.
7. Soini Y, Kinnula V, Wiik-Kaarteenaho R, Kurtilla E, Linnainmaa K, et al. (1999) Apoptosis and expression of apoptosis regulating proteins bcl-2, mcl-1, bcl-x and bax in malignant mesothelioma. Clin Cancer Res 5: 3508-3515.
8. Gottlieb E, Vander Heiden MG, Thompson CG (2000) Bcl-xL prevents the initial decrease in mitochondrial membrane potential and subsequent reactive oxygen species production during tumor necrosis factor alpha-induced apoptosis. Mol Cell Biol 20: 5680-5689.
9. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism and function. Cell 116: 281-297.
10. Hayashita Y, Osada H, Tatematsu Y, Yamada H, Yanagisawa K, et al. (2004) A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 65: 9628-9632.
11. Mott JL, Kobayahi S, Bronk SF, Gores GJ (2007) miR-29 regulates Mcl-1 protein expression and apoptosis. Oncogene 26: 6133-6140.
12. Shivdasani RA (2006) MicroRNAs: regulators of gene expression and cell differentiation. Blood 108: 3646-3653.
13. Weimer EAC (2007) The role of microRNAs in cancer: No small matter. Eur J Cancer 43: 1529-1544.
14. Xu C, Lu Y, Pan Z, Chu W, Luo X, et al. (2007) The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes. J Cell Sci 120: 3045-3052.
15. Xiao C, Srinivasan L, Calado DP, Patterson HC, Zhang B, et al. (2008) Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat Immunol 9: 405-414.
16. In LLA, Azmi MN, Halijah I, Khalijah A, Hasima NN (2010) 1′S-1′Acetoxyeugenol Acetate (AEA): A novel phenolpropanoid from Alpinia conchigera enhances the apoptotic effects of paclitaxel in MCF-7 cells through nuclear factor kappa-B inactivation. Anticancer Drugs 22: 424-434.
17. Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: 2002-2007.
18. Edgar R, Domrachev M, Lash AE (2002) Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30: 207-210.
19. Livak KJ (1997) Comparitive Ct Method. Relative Quantitation of Gene Expression. ABI Prism 7700 Sequence Detection System. User Bulletin No 2.
20. Lewis BP, Burge CB, Bartel BP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
21. Huang DW, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatic resources. Nat Protoc 4: 44-57.
22. Leech SH, Olie RA, Gautschi O, Simoes-Wust AP, Tschopp S, et al. (2000) Induction of apoptosis in lung-cancer cells following bcl-xL anti-sense treatment. Int J Cancer 4: 570-576.
23. Reeve JG, Xiong J, Morgan J, Bleehen NM (1996) Expression of apoptosis-regulatory genes in lung tumour cell lines: relationship to p53 expression and relevance to acquired drug resistance. Br J Cancer 10: 1193-1200.
24. He H, Jazdzewski K, Li W, Liyanarachchi S, Nagy R, et al. (2005) The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci U S A 102: 19075-19080.
25. Shi L, Cheng Z, Zhang J, Li R, Zhao P, et al. (2008) Hsa-miR-181a and hsa-miR-181b function as tumor suppressors in human glioma cells. Brain Res 1236: 185-193.
26. Gao W, Yu Y, Cao H, Shen H, Li X, et al. (2010) Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis. Biomed Pharmacother 64: 399-408.
27. Galluzzi L, Morselli E, Vitale I, Kepp O, Senovilla L, et al. (2010) miR-181a and miR-630 regulate cisplatin-induced cancer cell death. Cancer Res 5: 1793-1803.
28. Pan YZ, Morris ME, Yu AI (2009) MicroRNA-328 Negatively Regulates the Expression of Breast Cancer Resistance Protein (BCRP/ABCG2) in Human Cancer Cells. Mol Pharmacol 75: 1374-1379.
29. Testa JR, Bellacosa A (2001) AKT plays a central role in tumorigenesis. Proc Natl Acad Sci U S A 98: 10983-10985.
30. Jeon HS, Jen J (2010) TGF-b signaling and the role of inhibitory Smads in non-small cell lung cancer. J Thorac Oncol 5: 417-419.
31. Massagué J (2008) TGFβ in cancer. Cell 134: 215-230.
32. Gesbert E, Griffin JD (2000) Bcr/Abl activates transcription of the Bcl-X gene through STAT5. Blood 6: 2269-2276.
33. Sanchez-Ceja SG, Reyes-Maldonado E, Vazquez-Manriquez ME, Lopez-Luna JJ, Belmont A, et al. (2006) Differential expression of STAT5 and Bcl-xL, and high expression of Neu and STAT3 in non-small-cell lung carcinoma. Lung Cancer 2: 163-168.
34. Aviel-Ronen S, Blackhall FH, Shepherd FA, Tsao MS (2006) K-ras mutations in non-small-cell lung carcinoma: a review. Clin Lung Cancer 1: 30-38.
35. Slebos RJC, Kibbelaar RE, Dalesio O, Kooistra A, Stam J, et al. (1990) K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. N Engl J Med 323: 561-565.
36. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, et al. (2005) Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433: 769-773.
37. Linsley PS, Schelter J, Burchard J, Kibukawa M, Martin MM, et al. (2007) Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progression. Mol Cell Biol 27: 2240-2252.
38. He L, He X, Lim LP, de Stanchina E, Xuan Z, et al. (2007) A microRNA component of the p53 tumour suppressor network. Nature 447: 1130-1135.
39. Krek A, Grün D, Poy MN, Wolf R, Rosenberg L, et al. (2005) Combinatorial microRNA target predictions. Nat Genet 37: 495-500.
40. Ivanovska I, Cleary MA (2008) Combinatorial microRNAs working together to make a difference. Cell Cycle 7: 3137-3142.